Midodrine Oral Tablet
Sponsors
Institute of Liver and Biliary Sciences, India, Ahmed talaat ahmed aly, Cairo University, Noha Mansour, China National Center for Cardiovascular Diseases
Conditions
Acute-On-Chronic Liver FailureChronic Liver DiseaseCirrhosis, LiverElderlyHeart Failure With Reduced Ejection FractionHypotensionLV DysfunctionLiver Cirrhosis
Phase 2
the Effect of Oral Vasopressors for Liberation From IV Vasopressors in Spinal Shock
NCT04586790
Start: 2020-10-15End: 2021-01-28Target: 90Updated: 2020-10-14
Midodrine Effect on the Mortality Rates in Septic Shock Patients
CompletedNCT05778838
Start: 2022-11-07End: 2024-01-24Updated: 2025-03-03
Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension
Not yet recruitingNCT06405555
Start: 2024-08-01End: 2026-07-01Target: 56Updated: 2024-05-08
Unknown Phase
Effect of Midodrine on HVPG in Advanced Chronic Liver Disease
CompletedNCT04455464
Start: 2020-07-11End: 2021-12-13Updated: 2021-12-14
Efficacy of Albumin Plus Midodrine v/s Albumin Alone in Reducing Incidence of Paracentesis Induced Circulatory Dysfunctions in ACLF Patients.
NCT04474262
Start: 2020-07-15End: 2021-03-31Target: 150Updated: 2020-07-16
To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial)
NCT05060523
Start: 2021-09-19End: 2022-09-30Target: 220Updated: 2021-11-29
To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.
CompletedNCT05287100
Start: 2022-01-01End: 2023-05-30Updated: 2023-10-10
Midodrine for Prophylaxis Against Post Spinal Hypotension in Elderly Population
CompletedNCT05548985
Start: 2022-10-17End: 2023-07-15Updated: 2023-09-15
Treatment Strategy of Vasovagal Syncope
RecruitingNCT05803148
Start: 2023-04-05End: 2024-12-30Target: 184Updated: 2024-03-21